29 reports

  • 2.3 Acne Treatment
  • 2.3 Acne Treatment

Scope of the Report The report entitled “Global Acne Treatment Market: Size, Trends & Forecasts (2018-2022) Edition”, provides an analysis of the global acne treatment market with detailed analysis of market sizing and growth. The analysis includes market size in terms of value, market share by segments and by region. The...

  • Acne Treatment
  • Market Size
  • Actavis plc
  • Allergan plc
  • Foamix Ltd.
  • Other acne treatment
  • Products and services segmentation (2016)

About face: Growth will be constrained as consumers opt for prescription treatments Abstract Acne Treatment Manufacturing OTC The Acne Treatment Manufacturing OTC industry benefits from fairly stable demand for these products because acne-prone individuals consider them a necessary...

  • Acne Treatment
  • OTC
  • Pharmaceutical
  • United States
  • Demand

Global Market Study on Acne Treatment: Inflammatory Acne Segment Anticipated to Account for ## BPS Gain in Market Revenue Share During 2017 – 2025 ##.

  • Acne Treatment
  • OTC
  • Pharmaceutical
  • World
  • Market Size
  • Jan 12, 2018: Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form

Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H2 2018 Summary Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR...

  • Acne Treatment
  • Leukemia
  • United States
  • World
  • Product Initiative
  • ACNE TREATMENT ALGORITHM
  • MAJOR DRUG TARGETS FOR ACNE TREATMENT

Acne Vulgaris: Opportunity Analysis and Forecasts to 2026 Summary Acne vulgaris (acne) is currently one of the most common and well-established dermatology conditions, affecting around 90% of the world’s population at some point in their lifetime.The disease is a chronic, inflammatory dermatological...

  • Acne Treatment
  • Foamix Ltd.
  • Galderma S.A.
  • Novan, Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Recommendations for Antibiotic Therapy in Acne Treatment
  • Mechanism of Action of Current Available Treatments

Acne vulgaris, also known simply as acne, is a common, chronic, inflammatory disease of the glands that produce sebum (sebaceous follicles). This disease results in the formation of inflamed elevations (papules, pustules, nodules, and cysts), comedones (blackheads and whiteheads), and scars on the skin. Acne is one of the most common...

  • Acne Treatment
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • Recommendations for Antibiotic Therapy in Acne Treatment
  • Mechanism of Action of Current Available Treatments

Acne vulgaris, also known simply as acne, is a common, chronic, inflammatory disease of the glands that produce sebum (sebaceous follicles). This disease results in the formation of inflamed elevations (papules, pustules, nodules, and cysts), comedones (blackheads and whiteheads), and scars on the skin. Acne is one of the most common...

  • Acne Treatment
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • JAN 12, 2018: ORTHO DERMATOLOGICS ANNOUNCES U.S. FDA FILING ACCEPTANCE FOR IDP-121 ACNE TREATMENT IN LOTION FORM
  • GALDERMA SA

Acne Vulgaris - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Acne Vulgaris - Pipeline Review, H1 2018, provides an overview of the Acne Vulgaris (Dermatology) pipeline landscape. Acne vulgaris is a chronic skin disease...

  • Acne Treatment
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • Nadifloxacin Drugs for Acne Treatments
  • Tretinoin Drugs for Acne Treatments

Acne vulgaris, also known as acne, is a common, chronic, inflammatory disease of the glands that produce sebum (sebaceous follicles). This disease results in the formation of inflamed elevations (papules, pustules, nodules, and cysts), comedones (blackheads and whiteheads), and scars on the skin. Acne is one of the most common disorders...

  • Acne Treatment
  • India
  • Allergan plc
  • Cipla Ltd
  • Novartis AG
  • 1.4 TREATMENT
  • 3.2 THE US ACNE DRUGS REVENUE

Acne is defined as a chronic skin disorder in which the hair follicles become blocked and/or inflamed. There are several variants of acne and they range from mild to severe. The most common type of acne is acne vulgaris (vulgaris means common). Acne appears most often on the face, but can also be a nuisance on chest,...

  • Acne Treatment
  • North America
  • United States
  • World
  • Allergan plc
  • JAN 12, 2018: ORTHO DERMATOLOGICS ANNOUNCES U.S. FDA FILING ACCEPTANCE FOR IDP-121 ACNE TREATMENT IN LOTION FORM

Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Pipeline Review, H2 2018 Summary According to the recently published report ’Retinoic Acid Receptor Gamma - Pipeline Review, H2 2018’; Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor...

  • Acne Treatment
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Presence of alternatives for acne treatment ##. ##. ##.

  • Acne Treatment
  • APAC
  • World
  • Forecast
  • Market Size
  • 4.4 CURRENT PRESCRIPTION (RX) TREATMENTS FOR ACNE VULGARIS
  • 4.2 INCIDENCE AND PREVALENCE OF ACNE VULGARIS

The global dermatological (prescription) drugs market was valued at $38.4bn in 2017, GMR Data forecast that this will rise to $44.1bn across 2018. The third in a series of biennial Dermatology reports sees GMR Data again interview industry experts to produce a market leading report that dissects and investigates...

  • Acne Treatment
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.
  • ACNE VULGARIS - PIPELINE BY HOVIONE FARMACIENCIA SA, H2 2017
  • ACNE VULGARIS - PIPELINE BY HELIX BIOMEDIX INC, H2 2017

The abstract is entitled " BPX-## Minocycline ## percent topical Gel for the Treatment of Acne Vulgaris".

  • Acne Treatment
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • Official Title
  • Clinical Trial profile. 384 Trial Title

Acne And Related Disorders Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acne And Related Disorders Global Clinical Trials Review, H1, 2017" provides an overview of Acne And Related Disorders clinical trials scenario. This report provides top line data relating to the clinical...

  • Acne Treatment
  • Clinical Trial
  • Dermatological Condition
  • Pharmaceutical
  • World
  • Official Title
  • Clinical Trial profile. 419 Trial Title

Acne Vulgaris Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H1, 2017" provides an overview of Acne Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Acne Vulgaris. Report includes...

  • Acne Treatment
  • Clinical Trial
  • Pharmaceutical
  • World
  • Product Initiative

##.

  • Acne Treatment
  • OTC
  • APAC
  • World
  • Forecast
  • Market size and forecast
  • Acne drugs: Key buying criteria

Global Acne Drugs Market 2016-2020 Covering: This market research report presents a detailed segmentation of the global acne drugs market by drug class (antibiotics, anti-inflammatory drugs, antimicrobial, combination medications, hormonal agents, oral retinoid, and topical retinoid), by route of administration (topical, and oral), and...

  • Acne Treatment
  • Dermatological Condition
  • Allergan plc
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.
  • Clinical Trial profile. 408 Trial Title
  • Clinical Trial profile. 431 Trial Title

Acne Vulgaris Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2016" provides an overview of Acne Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Acne Vulgaris. Report includes an...

  • Acne Treatment
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative

Acne Phase ## Clinical Trials, 2016 ##.

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • Japan
  • Market Shares

US Acne Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Acne Treatments ##) Acne Pipeline ##) US Acne Epidemiology ##) Marketed Drugs for Acne in US ##) US Acne M

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • United States
  • Market Shares

Acne Phase ## Clinical Trials, 2016 ##.

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • Germany
  • Market Shares

UK Acne Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Acne Treatments ##) Acne Pipeline ##) UK Acne Epidemiology ##) Marketed Drugs for Acne in UK ##) UK Acne M

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • United Kingdom
  • Market Shares

Acne Phase ## Clinical Trials, 2016 ##.

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • Italy
  • Market Shares

Acne Phase ## Clinical Trials, 2016 ##.

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • France
  • Market Shares

Acne Phase ## Clinical Trials, 2016 ##.

  • Acne Treatment
  • Dermatological Condition
  • Pathology
  • Spain
  • Market Shares
  • ACNE VULGARIS - PIPELINE BY INNOVATION PHARMACEUTICALS INC,
  • ACNE VULGARIS - PIPELINE BY HELIX BIOMEDIX INC,

ACNES OF INFLAMMATORY CYTOKINE IL-## ALPHA SECRETION IN HUMAN KERATINOCYTES.

  • Acne Treatment
  • Allergy Drug
  • United States
  • Company
  • Product Initiative
  • Clinical Trial profile. 381 Trial Title
  • Clinical Trial profile. 391 Trial Title

Acne And Related Disorders Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Acne And Related Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Acne And Related Disorders clinical trials scenario. This report provides top line data relating to the clinical trials...

  • Acne Treatment
  • Clinical Trial
  • Pharmaceutical
  • World
  • Product Initiative
  • ACNE VULGARIS - PIPELINE BY HELIX BIOMEDIX INC,
  • ACNE VULGARIS - PIPELINE BY HOVIONE FARMACIENCIA SA,

Diana Harbort, CEO of Cassiopea SpA, commented: " The antibiotic segment is one of the largest markets for the treatment of acne.

  • Acne Treatment
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative